PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+17.18%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$109M
AUM Growth
–
Cap. Flow
+$109M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
40.45%
Holding
93
New
93
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
NeoGenomics
NEO
|
$7.36M |
| 2 |
Vericel Corp
VCEL
|
$5.13M |
| 3 |
Natera
NTRA
|
$5.11M |
| 4 |
CareDx
CDNA
|
$4.54M |
| 5 |
Idexx Laboratories
IDXX
|
$4.41M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 65.27% |
| 2 | Technology | 12.84% |
| 3 | Communication Services | 6.99% |
| 4 | Industrials | 4.39% |
| 5 | Consumer Staples | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.13B
| $7.36M | 6.76% | +199,525 | New | +$7.36M |
|
|
2
Vericel Corp
VCEL
$1.83B
| $5.13M | 4.71% | +276,897 | New | +$5.13M |
|
|
3
Natera
NTRA
$23.1B
| $5.11M | 4.69% | +70,700 | New | +$5.11M |
|
|
4
CareDx
CDNA
$727M
| $4.54M | 4.17% | +119,592 | New | +$4.54M |
|
|
5
Idexx Laboratories
IDXX
$51.8B
| $4.41M | 4.05% | +11,205 | New | +$4.41M |
|
6
Veracyte
VCYT
$2.39B
| $4.24M | 3.9% | +130,580 | New | +$4.24M |
|
7
OptimizeRx
OPRX
$335M
| $3.52M | 3.23% | +168,760 | New | +$3.52M |
|
8
Microsoft
MSFT
$3.77T
| $3.36M | 3.09% | +15,993 | New | +$3.36M |
|
9
Axogen
AXGN
$743M
| $3.33M | 3.06% | +286,190 | New | +$3.33M |
|
10
Abbott
ABT
$231B
| $3.05M | 2.8% | +28,030 | New | +$3.05M |
|
11
Standard BioTools
LAB
$481M
| $2.47M | 2.27% | +332,425 | New | +$2.47M |
|
12
FlexShopper
FPAY
$17M
| $2.15M | 1.98% | +1,217,130 | New | +$2.15M |
|
|
CSII
13
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.14M | 1.97% | +54,450 | New | +$2.14M |
|
14
Eli Lilly
LLY
$657B
| $2.07M | 1.9% | +13,958 | New | +$2.07M |
|
15
Rockwell Medical
RMTI
$58.9M
| $1.97M | 1.81% | +1,844,225 | New | +$1.97M |
|
16
Magnite
MGNI
$3.7B
| $1.92M | 1.77% | +277,000 | New | +$1.92M |
|
17
LeMaitre Vascular
LMAT
$2.16B
| $1.84M | 1.69% | +56,700 | New | +$1.84M |
|
18
BioLife Solutions
BLFS
$1.2B
| $1.84M | 1.69% | +63,650 | New | +$1.84M |
|
19
Castle Biosciences
CSTL
$696M
| $1.8M | 1.65% | +34,900 | New | +$1.8M |
|
20
Pfizer
PFE
$141B
| $1.78M | 1.63% | +48,373 | New | +$1.78M |
|
21
AtriCure
ATRC
$1.84B
| $1.77M | 1.63% | +44,350 | New | +$1.77M |
|
|
ASPU
22
DELISTED
ASPEN GROUP, INC.
ASPU
| $1.71M | 1.57% | +152,750 | New | +$1.71M |
|
23
Inuvo
INUV
$49.5M
| $1.7M | 1.56% | +4,640,211 | New | +$1.7M |
|
|
QUMU
24
DELISTED
Qumu Corp.
QUMU
| $1.66M | 1.53% | +361,000 | New | +$1.66M |
|
|
AKTS
25
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $1.59M | 1.46% | +195,300 | New | +$1.59M |
|